Guardant Health owes $83.4 mln in DNA sequencing patent case, US jury says

Directors Trey Powers, Byron Pickard, Chandrika Vira, William Milliken, Anna Phillips, and Tyler Dutton were mentioned as representing TwinStrand Biosciences in the Reuters article “Guardant Health owes $83.4 mln in DNA sequencing patent case, US jury says.” Following is an excerpt from the article:

“Precision oncology company Guardant Health (GH.O) was hit with an $83.4 million verdict by a jury in Delaware federal court, which found that its cancer-testing kits violate the patent rights of biotech company TwinStrand Biosciences and the University of Washington.

The jury said on Tuesday that Guardant’s genetic-sequencing technology infringes two patents and that the infringement was willful, which could lead to the award being multiplied.”